Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
James P. Buteau, Daniel Moon, Michael T. Fahey, Matthew J. Roberts, James Thompson, Declan G. Murphy, Nathan Papa, Catherine Mitchell, Richard De Abreu Lourenco, Haryana M. Dhillon, Veeru Kasivisvanathan, Roslyn J. Francis, Phillip Stricker, Shihka Agrawal, Jonathan O'Brien, Aoife McVey, Gaurav Sharma, Sidney Levy, Narjess Ayati, Andrew Nguyen, Su-Faye Lee, David A. Pattison, Dinesh Sivaratnam, Mark Frydenberg, Yang Du, Jehan Titus, Sze-Ting Lee, Joseph Ischia, Greg Jack, Michael S. Hofman & Louise Emmett. (2023) Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. European Urology Oncology.
Crossref
Crossref
Rulon Mayer, Baris Turkbey, Peter L. Choyke & Charles B. SimoneIIII. (2023) Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study. Diagnostics 13:20, pages 3238.
Crossref
Crossref
Thomas Whish-Wilson, Jo-Lynn Tan, William Cross, Lih-Ming Wong & Tom Sutherland. (2023) Prostate magnetic resonance imaging and the value of experience: An intrareader variability study. Asian Journal of Urology 10:4, pages 488-493.
Crossref
Crossref
Savannah R. Duenweg, Samuel A. Bobholz, Michael J. Barrett, Allison K. Lowman, Aleksandra Winiarz, Biprojit Nath, Margaret Stebbins, John Bukowy, Kenneth A. Iczkowski, Kenneth M. Jacobsohn, Stephanie Vincent-Sheldon & Peter S. LaViolette. (2023) T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence. Cancers 15:18, pages 4437.
Crossref
Crossref
Takaaki Yoshimura, Keisuke Manabe & Hiroyuki Sugimori. (2023) Non-Invasive Estimation of Gleason Score by Semantic Segmentation and Regression Tasks Using a Three-Dimensional Convolutional Neural Network. Applied Sciences 13:14, pages 8028.
Crossref
Crossref
Emilian Kalchev. (2023) Evaluating the Utility of Prostate-Specific Antigen Density in Risk Stratification of PI-RADS 3 Peripheral Zone Lesions on Non-Contrast-Enhanced Prostate MRI: An Exploratory Single-Institution Study. Cureus.
Crossref
Crossref
Artitaya Lophatananon, Alexander Light, Nicholas Burns-Cox, Angus Maccormick, Joseph John, Vanessa Otti, John McGrath, Pete Archer, Jonathan Anning, Stuart McCracken, Toby Page, Ken Muir & Vincent J Gnanapragasam. (2021) Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathways. Journal of Clinical Urology 16:4, pages 264-273.
Crossref
Crossref
David Eldred‐Evans, Martin J. Connor, Mariana Bertoncelli Tanaka, Edward Bass, Deepika Reddy, Uma Walters, Luke Stroman, Easter Espinosa, Raj Das, Nalin Khosla, Henry Tam, Elizabeth Pegers, Hasan Qazi, Stephen Gordon, Mathias Winkler & Hashim U. Ahmed. (2022)
The rapid assessment for prostate imaging and diagnosis (
RAPID
) prostate cancer diagnostic pathway
. BJU International 131:4, pages 461-470.
Crossref
Crossref
G. Fiard, A. Seigneurin, M. Roumiguié, S. Albisinni, J. Anract, G. Assenmacher, N. Barry Delongchamps, C. Dariane, A. Feyaerts, A. Fourcade, G. Fournier, P. Gontero, R. Mastroianni, M. Oderda, A. Peltier, T. Roumeguère, T. Saussez, G. Simone, J. Van Damme, J. L. Descotes, G. Ploussard & R. Diamand. (2023) Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy. World Journal of Urology.
Crossref
Crossref
Auke Jager, Arnoud W. Postema, Massimo Mischi, Hessel Wijkstra, Harrie P. Beerlage & Jorg R. Oddens. (2023) Clinical Trial Protocol: Developing an Image Classification Algorithm for Prostate Cancer Diagnosis on Three-dimensional Multiparametric Transrectal Ultrasound. European Urology Open Science 49, pages 32-43.
Crossref
Crossref
Alexandros Patsanis, Mohammed R.S. Sunoqrot, Sverre Langørgen, Hao Wang, Kirsten M. Selnæs, Helena Bertilsson, Tone F. Bathen & Mattijs Elschot. (2023) A comparison of Generative Adversarial Networks for automated prostate cancer detection on T2-weighted MRI. Informatics in Medicine Unlocked 39, pages 101234.
Crossref
Crossref
Jihui Song, Chenglin Zhao, Fei Zhang, Yingdi Yuan, Lee M. Wang, Vivek Sah, Jun Zhang, Wencai Weng, Zhenghan Yang, Zhenchang Wang & Liang Wang. (2022) The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI. Abdominal Radiology 48:2, pages 704-712.
Crossref
Crossref
Guglielmo Mantica, Nazareno Suardi, Salvatore Smelzo, Francesco Esperto, Francesco Chierigo, Stefano Tappero, Marco Borghesi, Roberto La Rocca, Marco Oderda, Marco Ennas, Armando Stabile, Francesco De Cobelli, Luigi Napolitano, Rocco Papalia, Paolo Gontero, Carlo Introini, Alberto Briganti, Roberto M. Scarpa, Vincenzo Mirone, Francesco Montorsi, Franco Gaboardi, Carlo Terrone & Gianpiero Cardone. (2022) Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation. Diagnostics 12:11, pages 2656.
Crossref
Crossref
Nikolaos Grivas, Michael Lardas, Estefania Linares Espinós, Thomas B. Lam, Olivier Rouviere, Nicolas Mottet & Roderick C.N. van den Bergh. (2022) Prostate Cancer Detection Percentages of Repeat Biopsy in Patients with Positive Multiparametric Magnetic Resonance Imaging (Prostate Imaging Reporting and Data System/Likert 3–5) and Negative Initial Biopsy. A Mini Systematic Review. European Urology 82:5, pages 452-457.
Crossref
Crossref
Ryan Alfano, Glenn S. Bauman, Jose A. Gomez, Mena Gaed, Madeleine Moussa, Joseph Chin, Stephen Pautler & Aaron D. Ward. (2022) Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology. European Journal of Radiology 156, pages 110494.
Crossref
Crossref
Christoph Würnschimmel, Thenappan Chandrasekar, Luisa Hahn, Tarik Esen, Shahrokh F. Shariat & Derya Tilki. (2022) MRI as a screening tool for prostate cancer: current evidence and future challenges. World Journal of Urology 41:4, pages 921-928.
Crossref
Crossref
Oscar J. Pellicer-Valero, José L. Marenco Jiménez, Victor Gonzalez-Perez, Juan Luis Casanova Ramón-Borja, Isabel Martín García, María Barrios Benito, Paula Pelechano Gómez, José Rubio-Briones, María José Rupérez & José D. Martín-Guerrero. (2022) Deep learning for fully automatic detection, segmentation, and Gleason grade estimation of prostate cancer in multiparametric magnetic resonance images. Scientific Reports 12:1.
Crossref
Crossref
Matteo Ferro, Ottavio de Cobelli, Gennaro Musi, Francesco del Giudice, Giuseppe Carrieri, Gian Maria Busetto, Ugo Giovanni Falagario, Alessandro Sciarra, Martina Maggi, Felice Crocetto, Biagio Barone, Vincenzo Francesco Caputo, Michele Marchioni, Giuseppe Lucarelli, Ciro Imbimbo, Francesco Alessandro Mistretta, Stefano Luzzago, Mihai Dorin Vartolomei, Luigi Cormio, Riccardo Autorino & Octavian Sabin Tătaru. (2022) Radiomics in prostate cancer: an up-to-date review. Therapeutic Advances in Urology 14, pages 175628722211090.
Crossref
Crossref
Luigi A.M.J.G. van Riel, Auke Jager, Dennie Meijer, Arnoud W. Postema, Ruth S. Smit, André N. Vis, Theo M. de Reijke, Harrie P. Beerlage & Jorg R. Oddens. (2022) Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator. Therapeutic Advances in Urology 14, pages 175628722210885.
Crossref
Crossref
Hala Maher Ahmed, Ahmed Ebrahim Ebeed, Ahmed Hamdy, Mohamed Abou El-Ghar & Ahmed Abdel Khalek Abdel Razek. (2021) Interobserver agreement of Prostate Imaging–Reporting and Data System (PI-RADS–v2). Egyptian Journal of Radiology and Nuclear Medicine 52:1.
Crossref
Crossref
Yeli Pi, Mitchell P. Wilson, Prayash Katlariwala, Medica Sam, Thomas Ackerman, Lee Paskar, Vimal Patel & Gavin Low. (2021) Diagnostic accuracy and inter-observer reliability of the O-RADS scoring system among staff radiologists in a North American academic clinical setting. Abdominal Radiology 46:10, pages 4967-4973.
Crossref
Crossref
Şehnaz TEZCAN, Ülkü BEKAR, Müge ONBAŞIOĞLU GÜRBÜZ & Giray ERGİN. (2021) The validity and agreement of PI-RADS v2 in the diagnosis of prostate cancer. Anatolian Current Medical Journal 3:4, pages 303-309.
Crossref
Crossref
Rajesh BhayanaAileen O'SheaMark A. AndersonWilliam R. BradleyRavi V. GottumukkalaAmirkasra MojtahedTheodore T. PierceMukesh Harisinghani. (2021) PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists. American Journal of Roentgenology 217:1, pages 141-151.
Crossref
Crossref
Ahmad Chaddad, Michael J. Kucharczyk, Abbas Cheddad, Sharon E. Clarke, Lama Hassan, Shuxue Ding, Saima Rathore, Mingli Zhang, Yousef Katib, Boris Bahoric, Gad Abikhzer, Stephan Probst & Tamim Niazi. (2021) Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review. Cancers 13:3, pages 552.
Crossref
Crossref
Borna K. Barth, Katharina Martini, Stephan M. Skawran, Florian A. Schmid, Niels J. Rupp, Laura Zuber & Olivio F. Donati. (2021) Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI. European Journal of Radiology Open 8, pages 100332.
Crossref
Crossref